The pharmaceutical executive Martin Shkreli made headlines this summer when he raised the price of a generic drug by over 5,000 percent. Led by Clay Wiske MD ’16, a team of researchers presented ...
A persistent drug shortage crisis in the U.S. is associated with higher mortality rates, medication errors, delays in life-saving cancer treatment and other critical medical procedures, and ...